| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |